my account  log out
 

Anti-ERBB2 (Trastuzumab-LC-K149)-DBCO-MMAF ADC

Create: 09/27/2017
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-K149) conjugated via a DBCO linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-erbb2-37.htm
City:[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer232
Feb 01 2023 GVBE Buffer232
Feb 01 2023 GVB++ (with Ca and Mg) Buffer239
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)226
Aug 30 2019Anti-HSV-2 gH Antibody419
Aug 30 2019Anti-L. major LPG Antibody501
Aug 30 2019Anti-DENV-1 Antibody410
Aug 30 2019Anti-BPV-1 L1 Antibody427
Aug 30 2019Anti-H3N2 HA Antibody408
Aug 30 2019Anti-EIAV env Antibody435

return back

Copyright © toextrade Inc. All rights reserved. Contact us